Amanote Research
Register
Sign In
The Significance of Galectin-3 as a New Basal Cell Marker in Prostate Cancer
Cell Death and Disease
- United Kingdom
doi 10.1038/cddis.2013.277
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Date
August 1, 2013
Authors
Y Wang
V Balan
X Gao
P G Reddy
D Kho
L Tait
A Raz
Publisher
Springer Science and Business Media LLC
Related search
TRIM29 as a Novel Prostate Basal Cell Marker for Diagnosis of Prostate Cancer
Acta Histochemica
Medicine
Histology
Cell Biology
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
PLoS ONE
Multidisciplinary
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
PLoS ONE
Multidisciplinary
Regulation of Prostate Cancer Progression by Galectin-3
American Journal of Pathology
Forensic Medicine
Pathology
Serum Galectin-3 Level as a Marker of Thrombogenicity in Atrial Fibrillation
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Intracellular Galectin-3 Inhibits Apoptosis in Human Prostate Cancer
Japanese Journal of Urology
Urology
P40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study With 34betaE12
Pathology Research International
Forensic Medicine
Pathology
Androgen Receptors Beyond Prostate Cancer: An Old Marker as a New Target
Oncotarget
Oncology
SSEA-3 as a Novel Amplifying Cancer Cell Surface Marker in Colorectal Cancers
International Journal of Oncology
Cancer Research
Oncology